Scalable Cell Replacement Therapies Developer Firm Eyestem Raises $6.4 Mn in Series-A Led by Three Pharma Majors

Dr Jogin Desai Founder/CEO with Eyestem Team Eyestem raises Series A round from Biological E, Alkem…